Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems—A Pharmaceutical Perspective

Cyclodextrins (CDs) are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits linked by α-1,4 glycosidic bonds. The shape of CD molecules is similar to a truncated cone with a hydrophobic inner cavity and a hydrophilic surface, which allows the formation of inclusion complexes with various molecules. This review article summarises over 200 reports published by the end of 2021 that discuss the complexation of CDs with antibiotics and antibacterial agents, including beta-lactams, tetracyclines, quinolones, macrolides, aminoglycosides, glycopeptides, polypeptides, nitroimidazoles, and oxazolidinones. The review focuses on drug-delivery applications such as improving solubility, modifying the drug-release profile, slowing down the degradation of the drug, improving biological membrane permeability, and enhancing antimicrobial activity. In addition to simple drug/CD combinations, ternary systems with additional auxiliary substances have been described, as well as more sophisticated drug-delivery systems including nanosponges, nanofibres, nanoparticles, microparticles, liposomes, hydrogels, and macromolecules. Depending on the desired properties of the drug product, an accelerated or prolonged dissolution profile can be achieved when combining CD with antibiotics or antimicrobial agents.

Bioapplication of cyclodextrin-containing montmorillonite

Recent progresses in the integration of CDs and montmorillonite, as well as applications of CD-containing montmorillonite hybrid host systems are summarized in this review. Several efficient synthesis strategies, such as ion exchange, metal coordination, supramolecular strategies, polymerizations and organic synthesis methods, have been discussed during the preparation of CDs/montmorillonite hybrid composites. In particular, diverse instrumental techniques were highly recommended for characterizing the as-obtained hybrid systems, including their chemical composition and structures, crystallinity, surface/self-assembled morphologies, as well as other particular physiochemical properties, providing a direct guide for promoting the desired structures and exploring various applications. It should be noted that the introduction of functional groups, as well as the integration of CDs and montmorillonite granted the thus obtained CD-containing montmorillonite hybrid host systems a lot of unique features, providing great opportunities for expanding the practical applications to a series of biological and environmental areas, such as biosensors, sorption and decontamination of bio/environmental hazardous materials, biostudies about aqueous dispersity, stability and biocompatibility, drug loading and target delivery, controlled and sustained drug release, as well as antibacterial.

α-Cyclodextrin Interacts Close to Vinblastine Site of Tubulin and Delivers Curcumin Preferentially to the Tubulin Surface of Cancer Cell

Tubulin is the key cytoskeleton component, which plays a crucial role in eukaryotic cell division. Many anticancer drugs have been developed targeting the tubulin surface. Recently, it has been shown that few polyhydroxy carbohydrates perturb tubulin polymerization. Cyclodextrin (CD), a polyhydroxy carbohydrate, has been extensively used as the delivery vehicle for delivery of hydrophobic drugs to the cancer cell. However, interaction of CD with intracellular components has not been addressed before. In this Article, we have shown for the first time that α-CD interacts with tubulin close to the vinblastine site using molecular docking and Förster resonance energy transfer (FRET) experiment. In addition, we have shown that α-CD binds with intracellular tubulin/microtubule. It delivers a high amount of curcumin onto the cancer cell, which causes severe disruption of intracellular microtubules. Finally, we have shown that the inclusion complex of α-CD and curcumin (CCC) preferentially enters into the human lung cancer cell (A549) as compared to the normal lung fibroblast cell (WI38), causes apoptotic death, activates tumor suppressor protein (p53) and cyclin-dependent kinase inhibitor 1 (p21), and inhibits 3D spheroid growth of cancer cell.

Transforming inorganic layered montmorillonite into inorganic–organic hybrid materials for various applications: a brief overview

The effects of various reaction parameters on the synthesis of silylated montmorillonites and several applications of these inorganic–organic layered materials are briefly overviewed in this review.

Stimuli-responsive, biocompatible hydrogel derived from glycogen and poly(N-isopropylacrylamide) for colon targeted delivery of ornidazole and 5-amino salicylic acid

A novel stimuli-responsive hydrogel (cl-Gly/pNIPAm) has been fabricated using biopolymer glycogen and N-isopropylacrylamide.

Modified biopolymer-dextrin based crosslinked hydrogels: application in controlled drug delivery

This review describes hydrogels and their classifications along with the synthesis and properties of biopolymer-dextrin based crosslinked hydrogels towards potential application in controlled drug delivery.

Dextrin/poly (HEMA): pH responsive porous hydrogel for controlled release of ciprofloxacin

Herein, we report an oral route administration for ciprofloxacin hydrochloride delivery using dextrin and poly (2-hydroxyethyl methylacrylate) based crosslinked hydrogel (c-Dxt/pHEMA). Various characteristics such as FTIR spectra, XRD analyses, UV-VIS-NIR spectra, FESEM and E-SEM analyses, rheological characteristics, gel kinetics, deswelling characteristics as well as biodegradation study of the hydrogel have been carried out. FTIR, XRD along with solid state UV-VIS-NIR analyses explain the good compatibility between the drug and the hydrogel matrix. The in vitro release study demonstrates that c-Dxt/pHEMA releases ciprofloxacin in a sustained way (33.75% of drug has been released in 18h) and is expected to be a promising matrix for ciprofloxacin carrier. The release kinetics and mechanism suggest that drug release follows first order kinetics and non-Fickian diffusion mechanism. Finally, the hydrogel shows excellent physical stability as carrier for ciprofloxacin up to 3 months.